Vol 58: Unveiling the Cracks: How VCs Expose and Strengthen Flawed Development Programs in CMC Drug Development
Revealing the Fault Lines: Unmasking VCs’ Role in Identifying and Enhancing Flawed CMC Drug Development Initiatives
Vol 57: The Role of Academic Institutions in Early Drug Development: CMC Opportunities and Challenges
Exploring the Crucial Role of Academic Institutions in Early Drug Development: Navigating CMC Opportunities and Overcoming Challenges
Case Study – MANUFACTURING SCALE-UP PROBLEMS IN A BIOLOGIC FOR A NEUROLOGICAL DISORDER
Emerging biotech resolved scalability issues in the manufacturing process, ensuring consistent quality and yield for neurological disorder treatment.
Vol 56: Developing a Drug from an Academic Discovery: Best Practices for Early CMC Development
Nurturing Academic Breakthroughs into Life-Changing Medicines: Key Steps in Early CMC Development
Vol 55: The Role of Venture Capital and CMC Drug Development: Strategies for Successful Collaboration
Unleashing Innovation: Harnessing Venture Capital and CMC Drug Development in a Powerful Collaboration
Vol 54: Best Practices for Addressing Impurities in CMC Submissions: A Short Comprehensive Guide for INDs and NDA/BLAs
Purging Impurities: Mastering CMC Submissions with Best Practices
Vol 53: Writing a Robust Stability Protocol for CMC Submissions
Ensuring Unwavering Confidence: Crafting a Resilient Stability Protocol for CMC Submissions
Vol 52: Developing a Regulatory CMC Strategy for Global Markets: Best Practices and Considerations
Developing a Regulatory CMC Strategy for Global Markets: Best Practices and Considerations
Vol 51: Streamlining CMC Development to Support Faster Regulatory Approval using Augmented Intelligence
Streamlining CMC Development to Support Faster Regulatory Approval using Augmented Intelligence
News 2023-05 BIO 2023
Enkrisi to showcase innovative regulatory and product development solutions at the BIO International Convention in Boston, MA, highlighting its commitment to driving success in the biotech and pharmaceutical industry.